Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Starboard Value Acquires Stake in Kenvue
Starboard reportedly takes big stake in Tylenol maker Kenvue
Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night.
Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its rivals, according to The Wall Street Journal.
Activist investor Starboard takes stake in Kenvue - WSJ
Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.
2d
on MSN
Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue
Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...
13h
Starboard says Kenvue's skin health segment weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Yahoo Finance
1d
Kenvue stock jumps on reports of Starboard Value's stake
The Wall Street Journal reported
Starboard
taking a "sizable stake" in the
Tylenol
and Band-Aids maker and hopes to boost ...
4h
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
15h
Starboard calls for Pfizer board to ‘hold management accountable’
Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback